In the BioHarmony Drug Report Database

"Preview" Icon

Pitavastatin

Nikita (pitavastatin) is a small molecule pharmaceutical. Pitavastatin was first approved as Nikita on 2017-08-04. It is used to treat hypercholesterolemia, hyperlipoproteinemias, and hypertriglyceridemia in the USA. It is known to target 3-hydroxy-3-methylglutaryl-Coenzyme A reductase.

 

Trade Name

 

Nikita
 

Common Name

 

pitavastatin
 

ChEMBL ID

 

CHEMBL1201753
 

Indication

 

hypercholesterolemia, hyperlipoproteinemias, hypertriglyceridemia
 

Drug Class

 

Enzyme inhibitors: antihyperlipidemics (HMG-CoA inhibitors)

Image (chem structure or protein)

Pitavastatin structure rendering